Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization.
about
Chronic fatigue and chronic fatigue syndrome in the general populationPharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome.The effects of ageing on the onset and disappearance of unexplained abdominal pain: a population-based study.Food intolerance and skin prick test in treated and untreated irritable bowel syndrome.Prevalence and risk factors of irritable bowel syndrome in Asia.Impact of functional gastrointestinal disorders on survival in the community.Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trialMeta-analysis: do irritable bowel syndrome symptoms vary between men and women?Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials.The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study.Patients with irritable bowel syndrome: health status and use of health care services.A comparison of irritable bowel syndrome patients managed in primary and secondary care: the Episode IBS study.Irritable bowel syndrome in a Bangladeshi urban community: prevalence and health care seeking pattern.What is the relevance of a systematic review of pharmacological management in irritable bowel syndrome to older people? Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study.Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome.Guidelines on the irritable bowel syndrome: mechanisms and practical management.A role for inflammation in irritable bowel syndrome?Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome.A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life.Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adultsOpioid bowel dysfunction and narcotic bowel syndrome: a population-based study.An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.Prevalence of hidden gastroparesis in the community: the gastroparesis "iceberg".Gender Role in Irritable Bowel Syndrome: A Comparison of Irritable Bowel Syndrome Module (ROME III) Between Male and Female PatientsChange in Quality of Life for Patients with Irritable Bowel Syndrome following Referral to a Gastroenterologist: A Cohort StudyPredictors of health care seeking for irritable bowel syndrome: a population based study.Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study.Canadian Digestive Health Foundation Public Impact Series 3: irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact.Association between psychological distress and gastrointestinal symptoms in diabetes mellitusNon-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders.Alcohol Use Disorder Increases the Risk of Irritable Bowel Disease: A Nationwide Retrospective Cohort StudyHistopathological alterations in irritable bowel syndrome.Irritable bowel syndrome: Quality of life and nursing interventions.Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatmentIrritable bowel syndrome and migraine: bystanders or partners?Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization.New treatments for irritable bowel syndrome in women
P2860
Q24791152-978D10F9-CECF-4D4D-AC51-E056AA547850Q33451900-0272EAEB-BC7B-4954-87A8-495342B21A5BQ33456815-DEFAB160-7D88-4B06-A2C9-73A672D3A35CQ33805614-62975BA9-72EF-4B9E-ADBE-788845B2C601Q33868855-0760414F-B74A-4A54-B2B1-8D01F5965EB2Q33890440-23E3BE44-DFE9-4429-99C5-53B4E8930A03Q33919405-577A769E-2C08-44B9-8D36-7A8E1667E36EQ33925230-1D982E9F-8F6A-4490-A84A-65A7085DC13BQ34101503-59E2E805-2E0B-4569-9D89-A2C00FF37310Q34179472-A25F6384-F1AF-4601-888B-C4D4C0DD1527Q34215474-7C41DFE6-2E41-4186-A3AC-84AE9178E899Q34217451-BD52FAC2-7136-4CAC-925B-7A724F8FC438Q34247606-473E4F40-D34A-4A3A-90B3-1598E21FCF8FQ34312352-1B3D9F48-0B2F-4D1D-9708-9608C7C0D0AEQ34370877-FC0E9EE3-266A-415B-BA39-6D64736F8235Q34403939-D72A0425-8047-4149-A2BF-9F2EEAC283A8Q34454007-273D8CEE-E1F6-4BD6-A356-A261732DB4CFQ34626602-5BAB81C8-8507-4677-81DF-CCAD46C7A1EAQ34699809-6F151FEC-B05E-4ED6-8B1E-16B990985151Q34786704-3CBA43AD-AF29-41AF-A9F6-CD8E3B0FED2CQ35200499-F6E2A477-F30C-4D4B-89ED-5F3AD31101F0Q35350671-2E44BA8C-076E-4357-AB1A-B487CA283ACAQ35364395-545B8FDD-4BBD-4703-BE35-F258DC5164CBQ35532548-C44E919D-7839-452C-9450-9DE758019FDCQ35595584-FBE00DA8-89A7-46A6-B063-12C4D1980E9EQ35730496-9D49E62A-5488-46F3-ACA7-A25955563929Q35730558-3135C443-97D4-4B64-B5DF-81B33500EE29Q35797307-520277FC-1301-44FA-92E2-A59216B86E66Q35841009-7986E6FC-8377-456B-9789-0C37319992F6Q35910817-DD3BE309-1BA6-4E1F-9669-CD26FC108337Q35962097-4B489BAD-95D7-4824-A125-CB7D86D0BD85Q36057076-54210C45-A40E-4C53-A37B-955918AEAA71Q36219973-273B1307-AE6A-4402-A14A-9BC66AF2A580Q36421071-B7CC4893-60EC-4D11-A89B-90192AB3DA92Q36609410-A33EA79D-6DA0-4D78-828D-C8F33FEDFD16Q36684872-EF55152F-B3C3-4D41-B316-F666EE251D66Q36803795-2BA69ECD-FC09-4909-9D88-9031368805D1Q37022341-7F2E17ED-4F8C-44DF-9C78-726A8D7C509EQ37108681-75E7C612-7B60-4937-A508-2208DCAC1DECQ37120300-2A126BC6-A91A-4A60-8022-7BA178A248EE
P2860
Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Irritable bowel syndrome in a ...... , and health care utilization.
@en
Irritable bowel syndrome in a ...... , and health care utilization.
@nl
type
label
Irritable bowel syndrome in a ...... , and health care utilization.
@en
Irritable bowel syndrome in a ...... , and health care utilization.
@nl
prefLabel
Irritable bowel syndrome in a ...... , and health care utilization.
@en
Irritable bowel syndrome in a ...... , and health care utilization.
@nl
P1476
Irritable bowel syndrome in a ...... , and health care utilization.
@en
P2093
Melton LJ 3rd
P356
10.1093/OXFORDJOURNALS.AJE.A117548
P407
P577
1995-07-01T00:00:00Z